|
GB9422096D0
(en)
*
|
1994-11-02 |
1994-12-21 |
Biocine Spa |
Combined meningitis vaccine
|
|
WO2002064091A2
(en)
*
|
2001-02-13 |
2002-08-22 |
Palatin Technologies, Inc. |
Melanocortin metallopeptides for treatment of sexual dysfunction
|
|
US5811102A
(en)
*
|
1995-06-07 |
1998-09-22 |
National Research Council Of Canada |
Modified meningococcal polysaccharide conjugate vaccines
|
|
JP4162267B2
(ja)
*
|
1996-08-27 |
2008-10-08 |
カイロン コーポレイション |
Ｎｅｉｓｓｅｒｉａ ｍｅｎｉｎｇｉｔｉｄｉｓ血清型Ｂ複合糖質およびその使用法
|
|
EP0922059B1
(en)
*
|
1996-08-27 |
2003-10-22 |
Chiron Corporation |
Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
|
|
PT1630168E
(pt)
|
1997-08-27 |
2011-07-20 |
Novartis Vaccines & Diagnostic |
Compostos miméticos moleculares de péptidos de meningococos do serogrupo b
|
|
GB9823835D0
(en)
*
|
1998-10-30 |
1998-12-23 |
Univ London |
Component for vaccine
|
|
EP1141375A4
(en)
*
|
1998-12-14 |
2002-06-05 |
Palatin Technologies Inc |
COMBINATIONAL LIBRARIES OF METAL OPEPTIDES AND THEIR USE
|
|
MXPA01012787A
(es)
|
1999-08-06 |
2005-08-26 |
Ivigene Corp |
Polinucleotidos microbianos expresados durante la infeccion de un huesped..
|
|
US7033748B2
(en)
*
|
1999-08-06 |
2006-04-25 |
Ivigene Corporation |
Identification of microbial polynucleotides expressed during infection of a host
|
|
US7049398B1
(en)
*
|
1999-08-12 |
2006-05-23 |
Palatin Technologies, Inc. |
Melanocortin metallopeptide constructs, combinatorial libraries and applications
|
|
US6838553B1
(en)
*
|
1999-10-05 |
2005-01-04 |
Academia Sinica |
Peptide repeat immunogens
|
|
US7189405B1
(en)
*
|
1999-10-29 |
2007-03-13 |
Rice Peter A |
Peptide mimics of conserved gonococcal epitopes and methods and compositions using them
|
|
AU1623801A
(en)
*
|
1999-11-19 |
2001-05-30 |
Palatin Technologies, Inc. |
Opioid metallopeptide compositions and methods
|
|
CA2871789C
(en)
*
|
2000-01-17 |
2017-04-04 |
Novartis Vaccines And Diagnostics S.R.L. |
Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins
|
|
GB0024200D0
(en)
*
|
2000-10-03 |
2000-11-15 |
Smithkline Beecham Sa |
Component vaccine
|
|
US7385025B2
(en)
|
2000-12-19 |
2008-06-10 |
Palatin Technologies, Inc. |
Metallopeptide compounds
|
|
US20020131953A1
(en)
*
|
2001-03-14 |
2002-09-19 |
Ut Southwestern Medical Center |
In situ langerhans cell vaccine
|
|
RU2322451C2
(ru)
*
|
2001-04-17 |
2008-04-20 |
Новартис Вэксинс Энд Диагностикс, Инк. |
Молекулярные миметики эпитопов менингококка в, которые вызывают выработку функционально активных антител
|
|
MX339524B
(es)
|
2001-10-11 |
2016-05-30 |
Wyeth Corp |
Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
|
|
CA2482747C
(en)
*
|
2002-04-19 |
2010-06-29 |
Yonsei University |
Vaccine composition for preventing meningococcal disease
|
|
EP1411061A1
(en)
|
2002-10-16 |
2004-04-21 |
Centre National De La Recherche Scientifique (Cnrs) |
Poly-alpha2,8-sialic acid mimetic peptides and their application
|
|
BRPI0411815A
(pt)
*
|
2003-06-23 |
2006-08-08 |
Baxter Int |
vacinas contra neisseria meningitidis do tipo y e suas combinações meningocócicas
|
|
NZ551625A
(en)
*
|
2004-05-11 |
2011-03-31 |
Abgenomics Cooperatief Ua |
T-cell death-inducing epitopes
|
|
WO2006002402A2
(en)
*
|
2004-06-23 |
2006-01-05 |
Children's Hospital & Research Center At Oakland |
Polysaccharide derivatives and uses in induction of an immune response
|
|
US8148335B2
(en)
|
2004-06-23 |
2012-04-03 |
Children's Hospital & Research Center Oakland |
De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
|
|
US8052971B2
(en)
*
|
2005-11-21 |
2011-11-08 |
MG Biologics |
Oral use of specific antibodies for intestinal health
|
|
US20080090760A2
(en)
*
|
2005-12-09 |
2008-04-17 |
Todd Hembrough |
Compositions and Methods for Inhibiting Cellular Proliferation
|
|
BRPI0620453A2
(pt)
*
|
2005-12-23 |
2011-11-08 |
Children's Hospital & Research Center At Oakland |
composições farmaceuticas compreendendo antìgenos de ácido siálico de-n-acetila e anticorpos para os mesmos, e seus usos
|
|
AR058736A1
(es)
*
|
2005-12-29 |
2008-02-20 |
Ct Ingenieria Genetica Biotech |
Peptidos mimeticos de carbohidratos y su empleo en formulaciones farmaceuticas
|
|
WO2007084856A2
(en)
*
|
2006-01-13 |
2007-07-26 |
Baxter International Inc. |
Method for purifying polysaccharides
|
|
GB0606155D0
(en)
*
|
2006-03-28 |
2006-05-10 |
Liverpool School Of Tropical M |
Bacterial vaccine
|
|
EP2007427A4
(en)
*
|
2006-04-11 |
2012-04-04 |
Yeda Res & Dev |
IMPROVED VACCINES WITH MULTIMETER HSP60 PEPTIDE SUPPORTS
|
|
GB0611914D0
(en)
*
|
2006-06-15 |
2006-07-26 |
Teti Giuseppe |
Peptides that mimic non-human cross-reactive protective epitopes of the group Bmeningococcal capsulsar polysaccharide
|
|
AR064642A1
(es)
|
2006-12-22 |
2009-04-15 |
Wyeth Corp |
Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
|
|
CN105267974A
(zh)
*
|
2007-06-20 |
2016-01-27 |
辉瑞爱尔兰制药公司 |
用于缀合疫苗的经过修饰的多糖
|
|
JP5523313B2
(ja)
*
|
2007-07-03 |
2014-06-18 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用
|
|
JP5702600B2
(ja)
*
|
2007-07-03 |
2015-04-15 |
チルドレンズ ホスピタル アンド リサーチ センター アット オークランド |
オリゴシアル酸誘導体、製造方法および免疫学的使用
|
|
US8999954B2
(en)
*
|
2007-07-03 |
2015-04-07 |
Childern's Hospital & Research Center at Oakland |
Inhibitors of polysialic acid de-N-acetylase and methods for using the same
|
|
US8067730B2
(en)
|
2007-07-20 |
2011-11-29 |
The George Washington University |
Laser ablation electrospray ionization (LAESI) for atmospheric pressure, In vivo, and imaging mass spectrometry
|
|
US20100285446A1
(en)
*
|
2007-07-20 |
2010-11-11 |
Akos Vertes |
Methods for Detecting Metabolic States by Laser Ablation Electrospray Ionization Mass Spectrometry
|
|
US7960336B2
(en)
|
2007-08-03 |
2011-06-14 |
Pharmain Corporation |
Composition for long-acting peptide analogs
|
|
US8563527B2
(en)
*
|
2007-08-20 |
2013-10-22 |
Pharmain Corporation |
Oligonucleotide core carrier compositions for delivery of nucleic acid-containing therapeutic agents, methods of making and using the same
|
|
US20090156459A1
(en)
*
|
2007-11-16 |
2009-06-18 |
Pharmain Corporation |
Cationic-Core Carrier Compositions for Delivery of Therapeutic Agents, Methods of Making and Using the Same
|
|
WO2009117409A2
(en)
*
|
2008-03-18 |
2009-09-24 |
Merck & Co., Inc. |
A high throughput protein interaction assay
|
|
AR077636A1
(es)
*
|
2009-07-08 |
2011-09-14 |
Abbott Biologicals Bv |
Vacuna viral y uso de la misma
|
|
PL3831406T3
(pl)
|
2010-08-23 |
2024-09-09 |
Wyeth Llc |
Stabilne preparaty antygenów rLP2086 Neisseria meningitidis
|
|
RU2546873C2
(ru)
|
2010-09-10 |
2015-04-10 |
УАЙТ ЭлЭлСи |
Нелипидизированные варианты антигенов neisseria meningitidis orf2086
|
|
WO2012054879A1
(en)
*
|
2010-10-22 |
2012-04-26 |
Duke University |
Compositions and methods for the treatment of septic arthritis, osteomyelitis, and bacteremia
|
|
WO2013085572A2
(en)
|
2011-07-14 |
2013-06-13 |
The George Washington University |
Plume collimation for laser ablation electrospray ionization mass spectrometry
|
|
EP2823312B1
(en)
*
|
2012-03-08 |
2019-08-07 |
GlaxoSmithKline Biologicals SA |
In vitro potency assay for protein-based meningococcal vaccines
|
|
SA115360586B1
(ar)
|
2012-03-09 |
2017-04-12 |
فايزر انك |
تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
|
|
MY167723A
(en)
|
2012-03-09 |
2018-09-21 |
Pfizer |
Neisseria meningitidis compositions and methods thereof
|
|
US9802987B2
(en)
|
2013-03-08 |
2017-10-31 |
Pfizer Inc. |
Immunogenic fusion polypeptides
|
|
WO2014179714A1
(en)
*
|
2013-05-03 |
2014-11-06 |
The Board Of Regents Of The University Of Texas System |
Generating peptoid vaccines
|
|
EP4098276A1
(en)
|
2013-09-08 |
2022-12-07 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
US10888611B2
(en)
|
2015-02-19 |
2021-01-12 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
PE20191107A1
(es)
|
2017-01-31 |
2019-08-26 |
Pfizer |
Composiciones de neisseria meningitidis y metodos respectivos
|
|
WO2021059181A1
(en)
|
2019-09-27 |
2021-04-01 |
Pfizer Inc. |
Neisseria meningitidis compositions and methods thereof
|
|
WO2021236790A1
(en)
*
|
2020-05-19 |
2021-11-25 |
Laboratory Corporation Of America Holdings |
Methods and systems for quantitative detection of antibodies
|